October 2026
Peginterferon lambda COVID-19 outcomes
StudyImprovementRR · 95% CIOutcomeTreatmentControlRelative Risk
Feld (DB RCT)0%1.00 · 0.07–15.26hosp.1/301/30ILIAD Cohort A
Feld (DB RCT)75%0.25 · 0.03–2.11ER visit1/304/30ILIAD Cohort A
Feld (DB RCT)66%0.34 · 0.09–0.91viral+6/3011/30ILIAD Cohort A
Jagannat.. (SB RCT)0%1.00 · 0.15–6.87hosp.2/602/60COVID-Lambda
Jagannat.. (SB RCT)−6%1.06 · 0.72–1.56no recov.60 (n)60 (n)COVID-Lambda
Jagannat.. (SB RCT)−14%1.14 · 0.14–9.17viral load60 (n)60 (n)COVID-Lambda
Reis (DB RCT)27%0.73 · 0.21–2.58death4/9316/1,018TOGETHER
Reis (DB RCT)61%0.39 · 0.05–1.95death1/9314/1,018TOGETHER
Reis (DB RCT)42%0.58 · 0.34–0.96hosp.21/93140/1,018TOGETHER
Reis (DB RCT)51%0.49 · 0.30–0.76hosp./ER25/93157/1,018TOGETHER
Kim (SB RCT)−200%3.00 · 0.14–63.15ICU1/70/7
Kim (SB RCT)−25%1.25 · 0.57–2.73hosp. time7 (n)7 (n)
Kim (SB RCT)12%0.88 · 0.31–2.44viral+3/64/7
Kim (SB RCT)−67%1.67 · 0.63–4.42viral+5/73/7
Kandel (DB RCT)−32%1.32 · 0.60–2.867-point status48 (n)46 (n)ILIAD Cohort B
00.511.52+